At the extraordinary general meeting in Hamlet Pharma AB on March 2, 2021 it was decided that the company''s common shares will undergo a split with relation 3:1 and be reclassified as A- and B-shares. The B-shares will be traded on Spotlight. The A-shares will not be listed. 

The reclassification means that the B-shares will be traded with a new ISIN code, share name, short name and FISN code. Last day of trading before the split and reclassification is March 12, 2021. The Company’s order book will be flushed due to the split. 

 

Last day of trading in the common share: March 12, 2021. 

First day of trading in the B-share after the split: March 15, 2021. 

Record date of the reclassification and split: March 16, 2021. 

 

Information about the common share: 

Share name: Hamlet Pharma 

Short name: HAMLET 

ISIN-code: SE0007192026 

Orderbook-ID: 413D 

CFI: ESVUFR 

FISN: HAMLETPHAR/SH 

Last day of trading before the reclassification: March 12, 2021 

 

Information about the B-share: 

Share name: Hamlet Pharma B 

Short name: HAMLET B 

ISIN-code: SE0015661152 

Orderbook-ID: 413D 

CFI: ESVUFR    

FISN: HAMLETPHAR/SH B 

First day of trading after the reclassification and split: March 15, 2021  

 

Information about the number of shares and the split; 

Terms: 3:1 

Number of common shares before the split: 33 624 899 

Number of shares after the split: 100 874 697 

Whereof: 

Number of A-shares: 67 249 798 

Number of B-shares: 33 624 899 

New Par Value: 0,01 SEK  

 

Stockholm March 11, 2021 

Spotlight Stock Market 
08-51168000  
trading@spotlightstockmarket.com